Meta-analysis of the hallmark cardiovascular and renal outcome trials addressing the risk for respiratory tract infections with sodium-glucose co-transporter-2 inhibitors: Implications for the COVID-19 pandemic.

Patoulias, Dimitrios; Papadopoulos, Christodoulos; Boulmpou, Aristi; Doumas, Michael

Patoulias, Dimitrios; Papadopoulos, Christodoulos; Boulmpou, Aristi; Doumas, Michael.

Afiliación

Patoulias D; Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital "Hippokration", Thessaloniki, Greece.
Papadopoulos C; Third Department of Cardiology, Aristotle University of Thessaloniki, General Hospital "Hippokration", Thessaloniki, Greece.
Boulmpou A; Third Department of Cardiology, Aristotle University of Thessaloniki, General Hospital "Hippokration", Thessaloniki, Greece.
Doumas M; Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital "Hippokration", Thessaloniki, Greece.

Diabetes Obes Metab ; 23(7): 1696-1700, 2021 Jul.

Article en En | MEDLINE | ID: mdl-33606909

Asunto(s)

COVID-19; Diabetes Mellitus Tipo 2; Inhibidores del Cotransportador de Sodio-Glucosa 2; Diabetes Mellitus Tipo 2/tratamiento farmacológico; Diabetes Mellitus Tipo 2/epidemiología; Glucosa; Humanos; Hipoglucemiantes/efectos adversos; Pandemias; SARS-CoV-2; Sodio; Transportador 2 de Sodio-Glucosa; Inhibidores del Cotransportador de Sodio-Glucosa 2/efectos adversos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 / COVID-19 Tipo de estudio: Etiology_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2021 Tipo del documento: Article País de afiliación: Grecia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google